Bath & Body Works (BBWI) to Announce Quarterly Earnings on Wednesday

Bath & Body Works (NYSE:BBWI) is expected to be releasing its Q2 2027 results before the market opens on Wednesday, August 26th. Analysts expect the company to announce earnings of $0.2432 per share and revenue of $1.4973 billion for the quarter. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Investors may review the information on the company’s upcoming Q2 2027 earning results page for the latest details on the call scheduled for Wednesday, August 26, 2026 at 8:30 AM ET.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The business’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same period last year, the firm earned $0.49 EPS. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Bath & Body Works Price Performance

BBWI opened at $19.16 on Tuesday. The firm has a market capitalization of $3.86 billion, a P/E ratio of 5.38, a price-to-earnings-growth ratio of 1.92 and a beta of 1.38. Bath & Body Works has a one year low of $14.27 and a one year high of $32.32. The company has a fifty day moving average price of $20.46 and a 200-day moving average price of $20.06.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 annualized dividend and a yield of 4.2%. Bath & Body Works’s dividend payout ratio (DPR) is currently 22.47%.

Institutional Investors Weigh In On Bath & Body Works

A number of hedge funds have recently made changes to their positions in the business. Geneos Wealth Management Inc. boosted its stake in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares in the last quarter. Danske Bank A S purchased a new position in Bath & Body Works in the 3rd quarter worth $39,000. Global Retirement Partners LLC purchased a new position in Bath & Body Works in the 4th quarter worth $31,000. Advisory Services Network LLC bought a new stake in Bath & Body Works in the third quarter worth $48,000. Finally, Parallel Advisors LLC lifted its stake in Bath & Body Works by 42.6% in the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after purchasing an additional 567 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on BBWI shares. Piper Sandler initiated coverage on Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 target price for the company. Jefferies Financial Group raised their price target on Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. JPMorgan Chase & Co. lifted their price target on Bath & Body Works from $22.00 to $24.00 and gave the company a “neutral” rating in a research report on Tuesday, August 18th. The Goldman Sachs Group lowered Bath & Body Works from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $23.00 to $19.00 in a report on Wednesday, July 8th. Finally, Telsey Advisory Group decreased their price objective on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research report on Thursday, May 28th. Four analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $22.57.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.